Piper Sandler Initiates Coverage on Black Diamond Therapeutics (NASDAQ:BDTX)

Piper Sandler initiated coverage on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a report released on Friday morning, Marketbeat Ratings reports. The firm issued an overweight rating and a $11.00 price objective on the stock. Other research analysts have also recently issued research reports about the stock. Wedbush upgraded shares of Black […]

Related Keywords

Davidm Epstein ,Ali Behbahani ,Stifel Nicolaus ,Piper Sandler ,Marquette Asset Management ,Diamond Therapeutics Inc ,Nasdaq ,Herbst Group ,Capital Management ,Securities Exchange Commission ,Dimensional Fund Advisors ,Cubist Systematic Strategies ,Diamond Therapeutics Company Profile ,Black Diamond Therapeutics ,Free Report ,Marketbeat Ratings ,Diamond Therapeutics ,Get Free Report ,Black Diamond ,Director Ali Behbahani ,Exchange Commission ,Systematic Strategies ,Asset Management ,Black Diamond Therapeutics Daily ,Nasdaq Bdtx ,Bdtx ,Medical ,Initiated Coverage ,